Pre-Interphex Showcase
Nanoencryption technology
NanoInk offers a
nanotechnology-based approach to fighting pharmaceutical counterfeiting and illegal diversion. The company deploys its patented "Nanoencryption" technology process to provide covert traceability at the unit-dosage level.
NanoInk, Skokie, IL
www.nanoink.net
tel. 847.679.NANO
Integrated blister line
The "Giant1" integrated blister line fully responds to sophisticated production requirements worldwide. The line is an alternative for the timely production of small and medium-sized batches. The product produces as many as 350 blisters/min and 175 cartons/min. The machine provides flexible operation and changeover and easy cleaning.
IMA Group, Bristol, PA
www.ima.it
tel. 215.826.8500
Capsule-filling and -sealing machine
Qualicaps offers a laboratory-sized, fully-automatic capsule-filling and -sealing machine for liquid-filling two-piece capsules. The unit is designed for small production batches and has a production capacity of 3000 capsules/h. The device fills capsule sizes from 00 to 5.
Qualicaps, Whitsett, NC
www.qualicaps.com
tel. 800.CAPSULE
Hypromellose capsules
CapsCanada offers "K-CAPS" pharmaceutical-grade hypromellose capsules. The capsules meet US Pharmacopeia requirements and can be used with all automatic filling machines without special change parts. K-CAPS capsules are free of preservatives and allergens. The products are Kosher and Halal certified. They are available in sizes 00, 1, 2, 3, and 4.
CapsCanada, Pompano Beach, FL
www.capscanadacorp.com
tel. 866.788.2888
Transfer packaging for prefillablesyringes
"BD TSCF" packaging
ensures the secure transfer of sterile prefillable syringe components into the pharmaceutical filling environment. The packaging is compatible with IDC "Biosafe" doors for aseptic filling machines within isolator or barrier systems. This packaging is part of the "BD SCF" global offer, which features expertise in sterile processing of preservative-free drugs; secure, reliable, easy-to-use systems; sterile, ready-to-fill; and drug master file and technical dossier.
BDMedical–Pharmaceutical Systems, Franklin Lakes, NJ
www.bdpharma.com
tel. 800.225.3310
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.